Clinical trial
Extension of Phase II Therapeutic Trial With a Humanized Non-Mitogenic CD3 (ChAgly CD3) Monoclonal Antibody in Recently Diagnosed Type 1 Diabetic Patients
NCT00627146 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Extension of Phase II Therapeutic Trial With a Humanized Non-Mitogenic CD3 (ChAgly CD3) Monoclonal Antibody in Recently Diagnosed Type 1 Diabetic Patients
- Lead sponsor
- Universitair Ziekenhuis Brussel
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2000
- Completion date
- March 31, 2007
- Enrollment
- 80 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.